Green NCAP tests reveal the realworld tradeoffs of electric and combustion cars
LEUVEN, BELGIUM – Green NCAP testing highlights the trade-offs drivers of both…
Mercedes star shines bright as Euro NCAPs final results deliver safer options for every buyer
LEUVEN, BELGIUM – Euro NCAP’s independent assessment of the new CLA shows…
European Protected Waveform Consortium Achieves Major Milestone with Successful Over-the-Air Testing
Demonstration underscores Europe's commitment to secure, resilient, multi-orbit military satellite communicationsSINT-NIKLAAS, Belgium,…
Euro NCAPs SAFER TRUCKS Programme wins Prince Michael International Road Safety Award 2025
Leuven, Belgium – Euro NCAP is proud to announce that its groundbreaking…
Euro NCAP announces 2026 protocol changes to tackle modern driving risks
LEUVEN, BELGIUM – Euro NCAP is making major changes to how it…
Euro NCAP announces test results for 23 new cars
LEUVEN, BELGIUM – The scores are in on Euro NCAP's biggest group…
From range anxiety to charging time: Green NCAP tests show how todays EVs perform in the real world
LEUVEN, BELGIUM – Green NCAP’s latest whole-life assessment of vehicles’ environmental impact…
adidas reveals largest ever collection of home kits ahead of FIFA World Cup 2026
adidas unveils 22 bespoke home kits, with bold new designs inspired by…
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas…
Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…
